CHILTON CAPITAL MANAGEMENT LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
CHILTON CAPITAL MANAGEMENT LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,088,884
+0.4%
10,690
-0.5%
0.06%
+3.4%
Q2 2023$1,084,077
+9.4%
10,743
-0.3%
0.06%
+3.5%
Q1 2023$991,300
-6.5%
10,775
-7.8%
0.06%
-13.6%
Q4 2022$1,060,698
+21.4%
11,692
+1.7%
0.07%
+13.8%
Q3 2022$874,0000.0%11,501
+11.3%
0.06%
+9.4%
Q2 2022$874,000
-4.4%
10,334
-0.9%
0.05%
+10.4%
Q1 2022$914,000
+28.0%
10,426
+27.8%
0.05%
+33.3%
Q4 2021$714,000
+1.9%
8,161
-4.8%
0.04%
-7.7%
Q3 2021$701,000
+10.9%
8,571
+23.8%
0.04%
+8.3%
Q2 2021$632,000
-94.8%
6,922
-95.1%
0.04%
-95.6%
Q1 2021$12,180,000
-14.5%
142,486
-5.5%
0.81%
-20.6%
Q4 2020$14,245,000
+8.5%
150,854
-0.1%
1.02%
-0.1%
Q3 2020$13,131,000
+6.8%
150,998
+7.2%
1.02%
-2.9%
Q2 2020$12,297,000
+10.3%
140,798
+4.2%
1.05%
-6.1%
Q1 2020$11,146,000
-9.8%
135,186
+3.6%
1.12%
+13.7%
Q4 2019$12,360,000
+8.6%
130,532
-0.4%
0.98%
+4.9%
Q3 2019$11,384,000
-4.6%
130,998
+0.2%
0.94%
-8.5%
Q2 2019$11,935,000
-6.2%
130,712
-1.2%
1.02%
-9.0%
Q1 2019$12,723,000
+13.9%
132,338
+1.7%
1.13%
+4.0%
Q4 2018$11,168,000
+2.9%
130,144
+3.3%
1.08%
+20.7%
Q3 2018$10,858,000
-37.0%
126,022
-44.8%
0.90%
+15.3%
Q2 2018$17,229,000
-4.6%
228,291
+2.1%
0.78%
-9.2%
Q1 2018$18,058,000
+4930.1%
223,560
+5135.6%
0.86%
+2497.0%
Q4 2017$359,000
+4.7%
4,270
+6.8%
0.03%0.0%
Q3 2017$343,000
+1.8%
3,997
-0.9%
0.03%
-10.8%
Q2 2017$337,000
-93.8%
4,032
-94.5%
0.04%
-93.2%
Q1 2017$5,457,000
-2.4%
73,469
-4.3%
0.54%
-7.4%
Q4 2016$5,589,000
-17.0%
76,731
-10.1%
0.58%
-13.8%
Q3 2016$6,736,000
-8.3%
85,315
-4.2%
0.68%
-4.6%
Q2 2016$7,346,000
+10.7%
89,036
-2.8%
0.71%
+7.1%
Q1 2016$6,637,000
-21.8%
91,617
-7.1%
0.66%
-25.3%
Q4 2015$8,484,000
-52.2%
98,606
-49.0%
0.89%
-3.9%
Q3 2015$17,758,000
+68.3%
193,200
+80.1%
0.93%
-6.8%
Q2 2015$10,550,000
+1.0%
107,280
+1.2%
0.99%
-5.2%
Q1 2015$10,450,000
+0.7%
105,975
-5.3%
1.05%
-0.5%
Q4 2014$10,373,000
-5.9%
111,945
-4.4%
1.05%
-10.0%
Q3 2014$11,028,000
+5.2%
117,157
+1.2%
1.17%
+14.6%
Q2 2014$10,480,000
-99.9%
115,763
+2.5%
1.02%
+1.6%
Q1 2014$9,603,689,000
+9.0%
112,958
+3.1%
1.01%
+5.9%
Q4 2013$8,809,487,000
+39.4%
109,598
+33.0%
0.95%
+31.2%
Q3 2013$6,321,134,000
+107402.3%
82,403
-0.9%
0.72%
-1.1%
Q2 2013$5,880,00083,1500.73%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders